can promote inflammation, in part through elicitation of proinflammatory cytokine production and recruitment of granulocytes, monocytes, and T lymphocytes. 10, 11 In addition, SAA also plays an important role in regulating the cellular proliferation and apoptosis. 12, 13 It has been demonstrated that SAA promotes the proliferation and survival of human fibroblast-like synoviocytes.
14 Recently, we and others have detected increased SAA mRNA and protein expression in psoriatic lesions. 15 , 16 Rooney et al. 16 reported that SAA is able to induce angiogenesis, a pathological hallmark of psoriasis. We demonstrated that SAA stimulated keratinocytes to produce IL-1β in a NLRP3 inflammasome-mediated mechanism, thereby providing positive feedback regulation of Th17 responses. 15 However, it is unknown whether SAA plays any role in the proliferation and differentiation of keratinocytes.
The aim of the present study was to determine the potential role of SAA in psoriasis. Our data showed that neutralising SAA could ameliorate epidermal hyperplasia and inflammation; we determined that SAA stimulated the proliferation and proinflammatory phenotype of normal human keratinocytes via binding to its receptor, formyl peptide receptor-like 1 (FPRL1), and that this effect is mediated by the activation of PI3K/Akt signalling pathway. These findings may constitute an attractive target for therapeutic interventions for psoriasis.
| MATERIALS AND METHODS

| Mice
Female BALB/c mice (8-to 11-week old) were purchased from the Shanghai SLAC Laboratory Animal Center, Chinese Academy of Science. All experiments were performed according to the Animal Care and Use Committee guidelines of Shanghai Skin Disease Hospital.
| Imiquimod-induced psoriasis-like mice
The imiquimod (IMQ)-induced psoriasis-like mice were constructed following previous protocols. 17, 18 The mice received a daily topical IMQ were sacrificed and skin specimens were collected and inspected. 
| RNA isolation and real-time PCR
| Histology and immunofluorescence
Mice back skin tissues were collected. The samples were fixed in 4% 
| Cell cultures
The normal human epidermal keratinocytes were cultured in accordance with a previously described procedure. 15 In brief, the keratinocytes were grown in EpiLife cell culture medium (Cascade Biologics, Portland, OR, USA) containing 0.03 or 1.2 mmol/L Ca2 + and 1×EpiLife
defined growth supplement at 37°C under standard tissue culture conditions. Stock cultures were maintained for up to five passages in this medium with the addition of gentamicin (10 μg/mL) and amphotericin B (0.25 μg/mL). Cells at 60-80% confluency were stimulated for different time periods with SAA (1-50 μg/mL; Peprotech, Rocky Hills, NJ, USA).
| Cell viability assay
A CCK-8 viability assay kit (Dojindo, Kumamoto, Japan) was adopted to analyse cell viability according to the manufacture's instruction. Briefly, cells were cultured in 96-well plates (Corning, Lowell, MA, USA) and incubated with 10 μL CCK-8 solution in 100 μL of fresh media for 3 hours at 37°C. The absorbance at 450 nm was detected after incubation. 
| Flow cytometry
| Co-immunoprecipitation
Keratinocytes were cultured to subconfluency in six-well plates (Corning). The cells were treated for 10 minutes with 20 μg/mL of SAA.
The cells were then harvested, and lysed in PBS with 1% Triton X-100, 0.5% sodium deoxycholate and 0.1% sodium dodecyl sulphate (PBS-TDS) as described previously. The protein concentration was determined by the bicinchoninic acid assay (BCA protein assay kit; Pierce, Rockford, IL, USA). Dynabeads protein G (25 μL) (Invitrogen) and 2 μg of anti-FPRL1 (ab63022; Abcam) were added to 500 μg protein samples.
After overnight incubation at 4°C on a rotator platform, the immunoprecipitate was collected, and brought down and boiled in the presence of SDS to liberate antigen. And then the immunoprecipitate was analysed by Western blot with an anti-SAA (sc-20275; Santa Cruz Biotechnology)
antibody following the same procedures as described above.
| Small interfering RNA (siRNA)
To reduce endogenous FPRL1 expression, keratinocytes were trans- PBS and maintained in defined keratinocyte-serum-free media. After expansion in culture for 72 hours, the cells were used for in vitro assays.
| Statistical analysis
All results are shown as mean and the standard error of the mean (mean ± SEM). The data were assessed for normal Gaussian distribution with Kolmogorov-Smirnov test. We used two-tailed Student's 
| RESULTS
| SAA is abundantly expressed in IMQ-induced psoriatic skin lesions
Given that increased SAA expression was found in human psoriasis skin lesions in our previous report, 15 we sought to explore its role in the pathogenesis of psoriasis. First, we established a psoriasis-like skin disorder in BALB/c mice using IMQ treatment, according to the previous reports. 17, 18 Then, we detected the SAA expression profile in the IMQ-treated mice. Using real-time PCR, we found that SAA expression in the back skins of IMQ-treated mice was significantly upregulated ( Figure 1A ). Moreover, immunofluorescence confirmed the increased SAA expression at protein level, especially in the epidermis of IMQ-treated mice ( Figure 1B ).
| Neutralisation of SAA ameliorates skin lesions in IMQ-induced psoriasis-like mice
To investigate the role of SAA in psoriatic lesion formation, we treated IMQ-induced psoriasis-like mice with SAA neutralising antibody. 
| SAA stimulates keratinocyte proliferation via the inhibition of differentiation genes
Keratinocyte proliferation and differentiation is critical in psoriatic epidermal hyperplasia; therefore, we next investigated whether SAA was involved in the regulation of keratinocyte proliferation and differentiation. When undifferentiated cultured keratinocytes were exposed to SAA, increased proliferation was observed as detected by an increase in cell number ( Figure 3A) . We also examined the keratinocyte proliferation in response to SAA using Ki67 staining. The percentage of Figure 3D ). Moreover, the Ca
2+
-increased expression of LOR mRNA in keratinocytes was abrogated by SAA ( Figure 3E ). These data suggest that SAA can both increase keratinocyte proliferation and inhibit differentiation, supporting a potential role of SAA in psoriasis.
| FPRL1 mediates SAA-induced proliferation of keratinocytes
Having demonstrated the involvement of SAA in the regulation of keratinocyte proliferation and differentiation, we next sought to explore the mechanism by which keratinocytes respond to SAA. FPRL1 is one of the potential receptors for SAA, and has been implicated in regulating cellular proliferation and survival. 14, 19 We thereby investigated by SAA was also blocked ( Figure 4F ). As shown in Figure 4G , silencing of FPRL1 also rescued SAA-induced LOR downregulation.
| SAA/FPRL1 stimulates the proinflammatory phenotype in keratinocytes
In psoriasis, keratinocytes produce proinflammatory mediators and upregulate immune-related surface markers. 
| SAA activates PI3K/Akt signalling pathway to regulate keratinocyte proliferation and differentiation
To further explore signalling pathways downstream of SAA/FPRL1, we analysed the activation of signalling molecules using Western blot. As shown in Figure 6A , phosphorylations of PI3K, Akt, Erk1/2 and NF-κB 
| DISCUSSION
In the present study, we found that SAA was upregulated in the lesional skin of IMQ-induced psoriasis-like mice. Neutralisation of Serum amyloid A is a highly conserved, acute phase plasma protein, which is synthesised predominantly by the liver. During acute inflammation, the liver directs a significant proportion of its synthetic capacity into producing SAA. 20 In addition to the liver, SAA is synthesised in various normal tissues such as kidney, breast and intestine, as well as in diseased tissues including atherosclerotic plaques, brain tissue of patients with Alzheimer' s disease and synovial tissue of patients with rheumatoid arthritis. [21] [22] [23] [24] In our previous study, as well as Rooney et al.
study showed that the expression of SAA was upregulated in psoriatic epidermis. 15, 16 To further investigate the expression and function of SAA in a mouse model of psoriasis, we adopted the well-described The upregulation of FPRL1 expression by SAA in our report suggests an increased sensitivity of keratinocytes to SAA, representing a self-enhancing mechanism. However, the regulatory mechanism of FPRL1 expression in keratinocytes is not well understood. Upregulation of FPRL1 by proinflammatory TNF-α and IL-1β has previously been observed in synovial fibroblasts. 28 Our data in keratinocytes extend the number of stimuli leading to FPRL1 upregulation by additionally identifying SAA as effective stimuli. As we previously reported that SAA induces the production of IL-1β from keratinocytes, 15 whether SAA upregulates FPRL1 expression in a direct or indirect way remains to be further investigated. A previous study suggested that Erk1/2 and NF-κB activation mediates the IFN-γ-induced FPRL1 expression in microglial cells. 31 As we showed that Erk1/2 and NF-κB were activated by SAA in our data, we postulated that these signalling molecules might be involved in SAA-induced FPRL1 upregulation.
Blockage of SAA-induced signalling pathways revealed specific functions in regard to proliferation and differentiation. Our present analysis indicated that PI3K/Akt was essential for SAA-induced keratinocyte proliferation. Although we previously demonstrated that NF-κB and NLRP3 inflammasome activation were required for SAA-mediated IL-1β production, blocking NF-κB or inflammasome pathways was not efficient in reducing SAA-stimulated proliferation in the present study.
It is very well known from different studies that PI3K/Akt signalling cascade is an important regulator of growth and proliferation of cells in hyperproliferative diseases like tumour and psoriasis. 32, 33 Thus, our study provides evidence that SAA utilises well-characterised pathways to induce proliferation and to inhibit differentiation in keratinocytes.
There are several potential mechanisms whereby SAA might exert positive effects on the pathogenesis of psoriasis. Firstly, as was suggested in this study, SAA, which is produced locally by keratinocytes, can exert a stimulatory effect on the proliferation of keratinocytes, while inhibiting cellular differentiation. Secondly, keratinocytes are now considered to play a key role as bona fide innate immune cells, capable of secreting cytokines, chemokines and antimicrobial peptides in response to various stimuli. In previous and present studies, we demonstrated that SAA could act as a DAMP by activating the proinflammatory cascades in keratinocytes. 15 Thirdly, SAA can promote neovascularisation, 16, 34, 35 a crucial hallmark of psoriasis pathogenesis. Consequently, activated keratinocytes might secrete increased quantities of SAA, which would then further stimulate the proliferation of keratinocytes in an autocrine manner, thereby forming a positive feedback loop. Considering that SAA production was induced by IL-17A, the key cytokine in psoriasis, SAA acts as a link in keratinocyte activation and skin inflammation, promoting the formation of a feed-forward and vicious cycle in psoriasis pathogenesis.
In conclusion, these findings support our discovery that SAA has a stimulatory role in keratinocyte proliferation and inflammation, leading to the formation of main pathological features of psoriasis. SAA was shown to induce the activation of keratinocytes, via its binding to 
